Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 2279212.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a double-blind placebo-controlled trial of 18 patients, methohexitone blocked objective signs of opiate withdrawal caused by a bolus injection of naloxone. Furthermore, in continuing the naloxone therapy for 48 hours, no withdrawal signs appeared. Levels of withdrawal distress returned to normal levels within six days. This approach can be regarded as an effective and well tolerated withdrawal therapy with low drop-out rates.
Medical subject headings
- Methohexital
- Naloxone
- Opioid-Related Disorders
- Substance Withdrawal Syndrome